The 7-repeat allele of the dopamine receptor D4 gene (DRD4) and the 10 repeat allele of the dopamine transporter gene (DAT1) have shown association and linkage with symptoms of attention deficit hyperactivity disorder (ADHD) in childhood. The parents of ADHD children (clinic group, n = 80 fathers and 107 mothers) and control children (control group, n = 42 fathers and 51 mothers) were the focus of this study. These parents reported retrospectively on their level of ADHD Inattention and Conduct Disorder symptoms in adolescence. In analyses of the relation of symptom levels to the DRD4 and DAT1 genotypes, fathers possessing the 7 repeat DRD4 allele had greater levels of both inattention and conduct disorder symptoms. Mothers with the 10/10 genotype had higher levels of inattention symptoms. Thus, genetic associations found in children may be replicable in their parents. Molecular Psychiatry (2001) 6, 429-433. This study focuses on two well-investigated genetic polymorphisms for attention deficit hyperactivity disorder (ADHD) in children. One is the 40-bp VNTR in the 3ЈUTR of the dopamine transporter gene (DAT1), while the other is the 48-bp repeat in exon III of the dopamine receptor D4 gene (DRD4). In the brain, the dopamine neurotransmitter system is involved in the attraction to reward and novelty.
This study focuses on two well-investigated genetic polymorphisms for attention deficit hyperactivity disorder (ADHD) in children. One is the 40-bp VNTR in the 3ЈUTR of the dopamine transporter gene (DAT1), while the other is the 48-bp repeat in exon III of the dopamine receptor D4 gene (DRD4). In the brain, the dopamine neurotransmitter system is involved in the attraction to reward and novelty. 1 The dopamine transporter gene, DAT1, encodes a protein that resides in axon membranes which recycle dopamine into the axon for subsequent reuse in transmitting nerve signals. DAT1 is the primary target of methylphenidate (Ritalin), a drug commonly used to treat hyperactive children, and cocaine, a drug commonly abused for its euphoric effects. 2, 3 These drugs block the transporter from reuptaking dopamine thus keeping more dopamine active at the synapse for longer periods of time. One hypothesis regarding the etiology of ADHD is that stimulants reduce hyperactivity because the higher basal level of dopamine dampens the voltage spike from nerve impulses. 4 This effect, however, is dosagedependent such that higher levels of methylpenidate would be excitatory, whereas lower levels would be inhibitory.
In this study, we examine a 40-base pair repeat polymorphism in the 3Ј-region of the gene. 5 The two most common gene variants are nine and ten copies of the repeats, although other rarer variants exist of fewer and greater numbers of repeats. 6 Repeat polymorphisms in genes have been shown to regulate gene expression. 7 That is, a certain number of repeats may upregulate a gene so that more mRNA is made from it, whereas other copy numbers may downregulate gene expression. A recent study suggests that this DAT1 VNTR polymorphism is functional as individuals who were heterozygous (9-repeat/10-repeat) had less DAT1 protein available in the putamen than did individuals who were homozygous for the 10-repeat. 8 A number of studies have shown that this polymorphism is associated and linked with ADHD in children. [9] [10] [11] [12] [13] The original study was done by Cook et al in Chicago with a population of clinic referred children.
11
There was an association between the 10-repeat gene variant, which is also the most common variant, and ADHD. This result was subsequently replicated by several research groups, including ours. 13 We also have found a relation between DAT1 and symptoms of oppositional defiant disorder (ODD) and conduct disorder (CD) (in preparation).
The second polymorphism examined resides in the dopamine receptor D4 gene. 14 The protein made by this gene resides in the dendritic membrane and signals the cell when dopamine binds to it. The polymorphism is a possibly functional 48-base pair repeat that is translated into amino acids in the resulting receptor molecule. In cell lines containing the D4 7 allele, cAMP formation in response to dopamine exposure was reduced about twofold when compared to D4 2-repeat and D4 4-repeat variants. 15 This polymorphism first gained attention with reports of its relation to the personality trait of novelty seeking in adults. 16, 17 Findings in subsequent studies have been mixed, with several replications and a number of non-replications. 18 There are many possible reasons for heterogeneity among studies, including the Molecular Psychiatry age range and ethnicity of respondents. One study of German college students and staff, using methods closely comparable to those used in the first reports of this association, yielded a successful replication. 19 The same polymorphism has been examined in relationship to ADHD in childhood, adolescent, and adult samples. The initial report by LaHoste et al found that the 7-repeat was associated with ADHD-combined type diagnosis. 20 In a meta-analysis of replication studies, linkage and association between the D4 gene 7-repeat allele and ADHD has been confirmed. 21 In this study, the two dependent variables were parents' retrospective reports of their ADHD Inattention and Conduct Disorder symptoms in adolescence. The control and clinic parents are likely to differ in mean levels of inattention and conduct disorder symptoms due to the familial nature of these behavior problems. Therefore, analyses of variance (ANOVAs) were conducted to compare the clinic and control parental means. These analyses were conducted separately for mothers and fathers for both dependent variables (2 parents × 2 variables = 4 ANOVAs). Each scale was square root transformed to reduce skewness. Except for mother's conduct disorder symptoms, the clinic parents had higher mean symptom levels (P Ͻ 0.01, onetailed) than the control parents. Except for mother's conduct disorder symptoms, the symptom scales were regressed on clinic status (1 = clinic parent; 0 = control parent), and residuals from this regression equation were used in the subsequent analysis. By using these residuals, we removed clinic vs control group differences as a source of association between each genetic marker and the symptom scales, a conservative approach because it removes one possibly legitimate source of association, that is, the clinic parents as a group being pre-selected for extreme symptoms through their clinic-referred child.
There was substantial assortative mating on conduct disorder symptoms (r = 0.43, n = 145 couples, P Ͻ 0.001) but not on inattention symptoms (r = 0.03, n = 145). We do not have symptom scores prior to marriage or partnership that would permit a more searching investigation of the influences leading to spousal resemblance on conduct disorder symptoms. Table 1 presents the frequency of high-risk alleles in the parents of clinic vs control children, and a Z-score test of the statistical significance between the two proportions. The DRD4 gene's high-risk allele had a greater frequency by 11% in clinic than in control mothers (P Ͻ 0.006). Although the frequency difference for this allele did not attain statistical significance in fathers, a 9% difference in allele frequency existed between clinic and control fathers (P Ͻ 0.104). The evidence was weaker for DAT1's high risk 10-allele. A trend existed for a greater frequency in clinic than control fathers (9% greater in clinic fathers, P Ͻ 0.075).
In our analyses of the relation of each polymorphism and the symptom scales, we contrasted the mean level of symptoms for high vs low risk genotypes. For both genes, one genotype was relatively rare (ie, the highrisk DRD4 7/7, Ͻ4% and the low-risk DAT1 9/9, Ͻ10%). For DRD4 gene, the 7/7 and 7/O (O = other allele) genotypes were combined and compared to all other genotypes. That is, the effect of possessing a highrisk 7-repeat allele vs all other alleles was estimated.
In the analyses of the DAT1 gene, both recessive and additive models were tested. In the recessive model, the 10/10 genotype was compared to all other genotypes. In the additive model, the 10/10 genotype was coded as 1.0, 10/O genotype as 0.5, and O/O genotype as zero. Table 2 presents the regression of symptom levels on DAT1 genotypes in the total sample and in the two subsamples (ie, clinic and control). The statistics included are the F value from the regression equation, the degrees of freedom (1.0 between-groups for two genotypic categories), the P value, the variance explained by genotype (r 2 as a measure of strength of association), and scale means for each genetic category. A second P value is shown for the additive model, but the other statistics are not presented because the recessive and additive models yielded comparable results. Most P values were slightly better for the recessive model. The regression models for fathers' symptoms yielded no significant associations for DAT1. In contrast, in mothers the predisposing 10/10 genotype increased the level of inattention symptoms, but not of conduct disorder symptoms. The effect sizes for mother's inattention ranged from 3.6% to 5.8% of the variance. Table 3 shows the regression of symptoms on possession of the 7-repeat D4 allele. Our hypothesis was that the 7-repeat allele would increase levels of inattention and conduct disorder symptoms. Two regressions were statistically significant for mothers. In the clinic sample, mothers possessing the 7-repeat allele had more conduct disorder symptoms than mothers possessing other genotypes. In the control mothers, however, this association was reversed because the nine mothers with high-risk 7-repeat alleles had a lower conduct disorder symptom level (M = 1.046, s = 0.05) than did the 42 mothers without a 7-repeat allele (M = 1.125, s = 0.12). Given the small number of control mothers possessing the high-risk allele, we do not place much emphasis on this contrary finding. In all fathers and clinic sample fathers, the effects of DRD4 were statistically significant and in the predicted direction for both inattention and conduct disorder symptoms. In the control fathers, the direction of the Molecular Psychiatry association was the same for conduct disorder symptoms, but failed to attain statistical significance. The statistically significant effects of DRD4 in fathers ranged from 3.6% to 5.2% of the variation in inattention and conduct disorder symptoms.
This initial exploration of the association of two genes, DAT1 and DRD4, with retrospective reports of conduct disorder symptoms and inattention symptoms of ADHD, yielded some positive findings. Of the two genes, the results most supportive of our hypotheses were those for DRD4. In fathers, the high-risk 7-repeat allele was associated with greater levels of both inattention and conduct disorder symptoms. Clinic parents also had a greater frequency of the 7-repeat allele. However, this outcome may be partly a function of the low 7-repeat allele frequency in our control group (ෂ10%). In European heritage people, estimates of the population prevalence of the 7-repeat allele in control samples or in samples unselected for psychiatric disorder vary widely (ie, from 12.8% to ෂ20%). 22, 23 A lower estimate of population prevalence would support our findings whereas a higher one would negate them. The only resolution of these conflicting estimates of allele frequency between cases and controls may be in the extensive genotyping of control and case individuals to test directly for population stratification effects. 24 Several features of the design may have attenuated the effects of the predisposing genotypes on retrospective reports of inattention and conduct disorder symptoms. First, the parental reports were retrospective to the teenage years, which may have decreased their validity. Second, the sample sizes were small for the detection of single gene effects on complex traits. Single genes that have been studied thus far explain less than 5% of symptom variance, and often only 1 or 2%. If a gene explained 4% of symptom variance, our statistical power was adequate for the total sample (n ෂ 150, power = 0.97) and in the clinic sample (n ෂ 100, power = 0.88), but inadequate in the control sample (n ෂ 50, power = 0.62). If a gene explained 2% of symptom variance, statistical power was acceptable only in the total sample (0.82). In light of these difficulties, the discovery of these positive associations should encourage obtaining behavioral data on parents in psychiatric studies of children. Either parents' retrospective or concurrent symptomology can be examined for associations with genetic markers. In addition to providing further support for genotypic effects, parental data may also be used to reveal potential heterogeneity in psychiatric genetic samples by contrasting offspring of affected and unaffected parents.
Methods

Sample
The participants in this study were parents of children enrolled in the joint Emory University and University of Arizona study of the genetics of childhood psychopathology. 12 The parents of one or more clinic-referred children are designated as being in the clinic group. The parents of non-referred children are designated as being in the control group. The control group was smaller than the clinic group because the recruitment of nonreferred families was suspended, as the study came to focus more specifically on affected children. The sample sizes were 80 clinic fathers, 107 clinic mothers, 42 control fathers, and 51 control mothers.
Measures
Conduct disorder symptoms Each parent was asked to recall his or her behavior between the ages of 14-18 years on a 15-item conduct disorder symptom scale. The wording of the items was based on the description of symptoms in the DSM-IV. Items were included pertaining to lying to others, staying out late without parental permission, skipping school, stealing, setting fires, vandalism, getting into physical fights, using weapons in a fight, using alcohol or drugs, and cruelty to people and animals. For each item, parents were asked to rate, 'how well the statement describes your behavior,' with four response choices: not at all = 0, just a bit = 1, pretty much = 2, and very much = 3. A measure of scale reliability, Cronbach's alpha coefficient, was 0.86 and 0.91 for mothers' and fathers' reports, respectively.
Inattention symptoms A second scale had 9 items written to match the DSM-IV inattention symptoms of ADHD. The items used the same response format and covered the same retrospective period as the conduct disorder symptom items. The Cronbach's alpha reliability coefficient was 0.92 and 0.91 for mothers and fathers reports, respectively.
DNA analysis
DNA was extracted from buccal cells using a high/low salt or diatom-binding method. The genotyping of the dopamine transporter gene (DAT1) and dopamine receptor D4 gene (DRD4) were conducted using standard protocols. 12, 25 
